CLINICAL_TRIALS
trial_result
· 2026-01-16
Clinical Trial Update: Immunogenicity of an Intradermal Qdenga Vaccine Among Healthy Volunteers [EARLY_Phase 1]
Summary
This early Phase 1 trial evaluated the immunogenicity of intradermal Qdenga (TAK-003) dengue vaccine in healthy volunteers; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Prince of Songkla University | Conditions: Dengue | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2026-01-16